Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Trivandrum cohort of the A(1)chieve study

由 Kesavadev, Jothydev
出版 2013

Liraglutide therapy beyond glycemic control: an observational study in Indian patients with type 2 diabetes in real world setting

由 Kesavadev, Jothydev, Shankar, Arun, Krishnan, Gopika, Jothydev, Sunitha
出版 2012

Sodium-glucose Cotransporter-2 Inhibitors in Combination with Other Glucose-lowering Agents for the Treatment of Type 2 Diabetes Mellitus

由 Kalra, Sanjay, Kesavadev, Jothydev, Chadha, Manoj, Kumar, G. Vijaya
發表在 Indian J Endocrinol Metab (2018)

Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas

由 Kesavadev, Jothydev, Saboo, Banshi, Krishna, Meera B., Krishnan, Gopika
發表在 Diabetes Ther (2020)

Management Strategies for Dealing With Surges of the COVID-19 Pandemic

由 Raveendran, A.V., Kesavadev, Jothydev, Hari, Parameswaran, Krishnan, Gopika
發表在 Cureus (2021)

Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy

由 Kesavadev, Jothydev, Saboo, Banshi, Shankar, Arun, Krishnan, Gopika, Jothydev, Sunitha
發表在 Indian J Endocrinol Metab (2015)

The Do-It-Yourself Artificial Pancreas: A Comprehensive Review

由 Kesavadev, Jothydev, Srinivasan, Seshadhri, Saboo, Banshi, Krishna B, Meera, Krishnan, Gopika
發表在 Diabetes Ther (2020)

Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)

由 Kesavadev, Jothydev, Pillai, Pradeep Babu Sadasivan, Shankar, Arun, Krishnan, Gopika, Jothydev, Sunitha
發表在 Endocr Connect (2017)

Steroid use during COVID-19 infection and hyperglycemia – What a physician should know

由 Sosale, Aravind, Sosale, Bhavana, Kesavadev, Jothydev, Chawla, Manoj, Reddy, Sanjay, Saboo, Banshi, Misra, Anoop
發表在 Diabetes Metab Syndr (2021)

Time-in-range as a target in type 2 diabetes: An urgent need

由 Saboo, Banshi, Kesavadev, Jothydev, Shankar, Arun, Krishna, Meera B., Sheth, Shruti, Patel, Vidisha, Krishnan, Gopika
發表在 Heliyon (2021)

Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization

由 Kesavadev, Jothydev, Misra, Anoop, Saboo, Banshi, Aravind, S.R., Hussain, Akhtar, Czupryniak, Leszek, Raz, Itamar
發表在 Diabetes Metab Syndr (2021)

Exploratory CSII Randomized Controlled Trial on Erectile Dysfunction in T2DM Patients (ECSIITED)

由 Kesavadev, Jothydev, Sadasivan Pillai, Pradeep Babu, Shankar, Arun, Warrier, Rohit S., Ramachandran, Lakshmy, Jothydev, Sunitha, Krishnan, Gopika
發表在 J Diabetes Sci Technol (2018)

Understanding Patients’ Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market

由 Murthy, Sreenivasa, Aneja, Pankaj, Asirvatham, Arthur Joseph, Husemoen, Lise Lotte N., Rhee, Nicolai A., Kesavadev, Jothydev
發表在 Pharmacoecon Open (2021)

Use of Insulin Pumps in India: Suggested Guidelines Based on Experience and Cultural Differences

由 Kesavadev, Jothydev, Das, Ashok Kumar, Unnikrishnan, Ranjit, Joshi, Shashank R., Ramachandran, Ambady, Shamsudeen, Jisha, Krishnan, Gopika, Jothydev, Sunitha, Mohan, Viswanathan
出版 2010

Our First 825 T2DM Patients on 14-Day Factory-Calibrated Glucose Monitoring System: Clinical Utility and Challenges

由 Kesavadev, Jothydev, Shankar, Arun, Ashok, Ashwin David, Srinivas, Sheeja, Ajai, Neethu Annie, Sanal, Geethu, Krishnan, Gopika, Ramachandran, Lakshmy, Jothydev, Sunitha
發表在 J Diabetes Sci Technol (2017)

Challenges in Type 1 diabetes management in South East Asia: Descriptive situational assessment

由 Kesavadev, Jothydev, Sadikot, Shaukat M., Saboo, Banshi, Shrestha, Dina, Jawad, Fatema, Azad, Kishwar, Wijesuriya, Mahendra Arunashanthi, Latt, Tint Swe, Kalra, Sanjay
出版 2014

Unproven Therapies for Diabetes and Their Implications

由 Kesavadev, Jothydev, Saboo, Banshi, Sadikot, Shaukat, Das, Ashok Kumar, Joshi, Shashank, Chawla, Rajeev, Thacker, Hemant, Shankar, Arun, Ramachandran, Lakshmy, Kalra, Sanjay
發表在 Adv Ther (2016)

Suggested use of vaccines in diabetes

由 Kesavadev, Jothydev, Misra, Anoop, Das, Ashok Kumar, Saboo, Banshi, Basu, Debasis, Thomas, Nihal, Joshi, Shashank R., Unnikrishnan, A. G., Shankar, Arun, Krishnan, Gopika, Unnikrishnan, Ranjit, Mohan, Viswanathan
出版 2012

Barriers and solutions to diabetes management: An Indian perspective

由 Wangnoo, Subhash K., Maji, Debasish, Das, Ashok Kumar, Rao, P. V., Moses, Anand, Sethi, Bipin, Unnikrishnan, Ambika Gopalakrishnan, Kalra, Sanjay, Balaji, V., Bantwal, Ganapathi, Kesavadev, Jothydev, Jain, Sunil M., Dharmalingam, Mala
出版 2013

Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel

由 Chawla, Manoj, Jain, Sunil M., Kesavadev, Jothydev, Makkar, Brij M., Viswanathan, Vijay, Tiwaskar, Mangesh, Sosale, Aravind R., Negalur, Vijay, Modi, Kirtikumar D., Gupta, Mukulesh, Kumar, Surinder, Ramakrishnan, Santosh, Deka, Nilakshi, Roy, Nirmalya
發表在 Diabetes Ther (2020)